文献速递类风湿关节炎其他结缔组织病

类风湿关节炎相关支气管扩张的患病率与危险因素:系统评价与Meta分析

Prevalence and risk factors of bronchiectasis in rheumatoid arthritis: A systematic review and meta-analysis.
PubMed 文献 · Semin Arthritis Rheum · 2021-08-20

该研究系统检索PubMed与EMBASE,纳入41项研究,其中36项报告患病率,共8569例RA患者中识别608例RA-BR。随机效应模型合并患病率为18.7%(95%CI 13.7-24.3%),采用高分辨率胸部CT(HRCT)的研究为22.6%(95%CI 16.8-29.0%)。危险因素包括年龄较大、RA病程较长、CFTR与HLA遗传因素及循环甘露糖结合凝集素(MBL)检测不到。

要点

  • HRCT研究中RA-BR合并患病率达22.6%,提示支气管扩张可能是RA常见关节外表现
  • 随机效应模型合并患病率为18.7%,固定效应模型为3.8%,研究间异质性明显
  • 相关危险因素较少,包括高龄、长病程、CFTR/HLA及MBL检测不到

核心结论

  • 在采用HRCT影像的研究中RA-BR患病率接近20%,提示支气管扩张可能是RA常见的关节外特征。
  • 与RA-BR相关的因素相对较少,未来研究需标准化RA-BR识别方法并探究其自然史与临床病程。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed和EMBASE数据库,共纳入41项研究,其中报告患病率34项、危险因素5项、两者兼有2项。
  • 患病率分析纳入36项研究,共8569例RA患者中识别608例RA-BR;研究间识别RA-BR的方法存在异质性。

主要发现

  • 随机效应模型合并RA-BR总患病率为18.7%(95%CI 13.7-24.3%),固定效应模型为3.8%(95%CI 3.3-4.2%)。
  • 采用HRCT影像的研究中,随机效应模型合并患病率为22.6%(95%CI 16.8-29.0%)。
  • 回顾性研究(n=12)合并患病率为15.5%(95%CI 7.5-25.5%),前瞻性研究(n=24)为20.7%(95%CI 14.7-27.4%)。
  • RA-BR的危险因素包括年龄较大、RA病程较长、遗传因素(CFTR和HLA)以及循环甘露糖结合凝集素(MBL)检测不到。

关键数值与推荐

  • RA-BR合并患病率:随机效应18.7%(95%CI 13.7-24.3%),固定效应3.8%(95%CI 3.3-4.2%)。
  • HRCT研究合并患病率22.6%(95%CI 16.8-29.0%);回顾性研究15.5%(95%CI 7.5-25.5%);前瞻性研究20.7%(95%CI 14.7-27.4%)。

临床怎么用

  • 对RA患者,尤其高龄、长病程者,应关注支气管扩张这一关节外表现的可能。
  • 影像学评估采用HRCT时需留意RA-BR的高患病率,结合遗传与MBL等生物标志物识别高风险患者。

局限性

  • 纳入研究识别RA-BR的方法异质性较大,可能影响患病率合并结果的解释。
  • 与RA-BR相关的危险因素研究数量较少,证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We performed a systematic review and meta-analysis for the prevalence and risk factors of rheumatoid arthritis-related bronchiectasis (RA-BR). METHODS: We queried PubMed and EMBASE databases to identify published literature related to prevalence and risk factors for RA-BR among patients with RA. Data extraction included study design, country, year, method of RA-BR detection, RA characteristics, numerator of RA-BR cases and denominator of patients with RA, and associations with RA-BR presence. We performed a meta-analysis using random or fixed effects models to estimate the prevalence of RA-BR among RA. RESULTS: Out of a total of 253 studies, we identified 41 total studies that reported on prevalence (n = 34), risk factors (n = 5), or both (n = 2). The included studies had heterogeneous methods to identify RA-BR. Among the 36 studies reporting prevalence, 608 RA-BR cases were identified from a total of 8569 patients with RA. In the meta-analysis, the pooled overall prevalence of RA-BR among RA was 18.7% (95%CI 13.7-24.3%) using random effects and 3.8% (95%CI 3.3-4.2%) using fixed effects. Among studies that used high-resolution chest computed tomography (HRCT) imaging, the prevalence of RA-BR was 22.6% (95%CI 16.8-29.0%) using random effects. When only considering retrospective studies (n = 12), the pooled prevalence of RA-BR among RA was 15.5% (95%CI 7.5-25.5%); among prospective studies (n = 24), the pooled prevalence was 20.7% (95% CI 14.7-27.4%). Risk factors for RA-BR included older age, longer RA duration, genetics (CFTR and HLA), and undetectable circulating mannose binding lectin (MBL) as a biomarker. CONCLUSION: In this systematic review and meta-analysis, the prevalence of RA-BR was nearly 20% among studies with HRCT imaging, suggesting that bronchiectasis may be a common extra-articular feature of RA. Relatively few factors have been associated with RA-BR. Future studies should standardize methods to identify RA-BR cases and investigate the natural history and clinical course given the relatively high prevalence among RA.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Martin LW, Prisco LC, Huang W, et al. Prevalence and risk factors of bronchiectasis in rheumatoid arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2021. PMID: 34450505. doi:10.1016/j.semarthrit.2021.08.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。